Accession Number: | 0001104659-21-143142 |
Date: | 2021-11-19 |
Issuer: | POSEIDA THERAPEUTICS, INC. (PSTX) |
Original Submission Date: |
MALIN LIFE SCIENCES HOLDINGS LTD
THE LENNOX BUILDING
50 RICHMOND STREET SOUTH
DUBLIN, IRELAND, L2 D02 FK02
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-11-19 | P | 11,104 | a | $7.44 | 9,578,605 | direct | ||
COMMON STOCK | 2021-11-23 | P | 14,625 | a | $6.77 | 9,593,230 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the reported prices in column 4 are weighted average prices. those shares were purchased in multiple transactions at per share prices ranging from $7.37 to $7.54 on 11/19/2021; and $6.695 to $6.89 on 11/23/2021. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |